PMVP: Pmv Pharmaceuticals Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Pmv Pharmaceuticals Inc (PMVP).
$78.14M Market Cap.
PMVP Market Cap. (MRY)
PMVP Shares Outstanding (MRY)
PMVP Assets (MRY)
Total Assets
$191.29M
Total Liabilities
$15.21M
Total Investments
$142.42M
PMVP Income (MRY)
Revenue
$0
Net Income
-$58.71M
Operating Expense
$85.45M
PMVP Cash Flow (MRY)
CF Operations
-$51.28M
CF Investing
$53.35M
CF Financing
$313.00K
PMVP Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $191,288,000 (-24.14%) | $252,152,000 (-6.72%) | $270,308,000 (-18.48%) | $331,568,000 (-9.29%) |
Assets Current | $175,658,000 (-15.31%) | $207,409,000 (-16.03%) | $247,006,000 (-18.02%) | $301,286,000 (-17.40%) |
Assets Non-Current | $15,630,000 (-65.07%) | $44,743,000 (92.01%) | $23,302,000 (-23.05%) | $30,282,000 (3832.73%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $176,080,000 (-21.98%) | $225,689,000 (-8.27%) | $246,028,000 (-20.27%) | $308,559,000 (-14.08%) |
Property Plant & Equipment Net | $1,552,000 (-91.85%) | $19,048,000 (-7.06%) | $20,494,000 (55.85%) | $13,150,000 (2211.07%) |
Cash & Equivalents | $40,876,000 (6.09%) | $38,528,000 (-64.69%) | $109,119,000 (-37.03%) | $173,289,000 (-52.05%) |
Accumulated Other Comprehensive Income | $139,000 (-37.95%) | $224,000 (150.34%) | -$445,000 (-470.51%) | -$78,000 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $142,421,000 (-25.38%) | $190,856,000 (41.11%) | $135,252,000 (-4.49%) | $141,607,000 (0%) |
Investments Current | $128,578,000 (-22.24%) | $165,351,000 (24.55%) | $132,757,000 (6.46%) | $124,696,000 (0%) |
Investments Non-Current | $13,843,000 (-45.72%) | $25,505,000 (922.24%) | $2,495,000 (-85.25%) | $16,911,000 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $6,579,000 (103.24%) | $3,237,000 (8.04%) | $2,996,000 (-6.05%) | $3,189,000 (98.44%) |
Accumulated Retained Earnings (Deficit) | -$368,712,000 (-18.94%) | -$310,003,000 (-28.61%) | -$241,043,000 (-43.71%) | -$167,726,000 (-52.64%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $1,190,000 (-91.04%) | $13,286,000 (-4.94%) | $13,976,000 (24.86%) | $11,193,000 (0%) |
Debt Current | $352,000 (-58.69%) | $852,000 (61.36%) | $528,000 (31.02%) | $403,000 (0%) |
Debt Non-Current | $838,000 (-93.26%) | $12,434,000 (-7.54%) | $13,448,000 (24.63%) | $10,790,000 (0%) |
Total Liabilities | $15,208,000 (-42.53%) | $26,463,000 (8.99%) | $24,280,000 (5.52%) | $23,009,000 (258.95%) |
Liabilities Current | $14,370,000 (2.43%) | $14,029,000 (29.51%) | $10,832,000 (-11.35%) | $12,219,000 (90.62%) |
Liabilities Non-Current | $838,000 (-93.26%) | $12,434,000 (-7.54%) | $13,448,000 (24.63%) | $10,790,000 (0%) |
PMVP Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $26,921,000 (11.03%) | $24,247,000 (-3.21%) | $25,052,000 (14.92%) | $21,800,000 (98.02%) |
Research & Development Expense | $58,527,000 (4.73%) | $55,885,000 (7.50%) | $51,988,000 (42.46%) | $36,493,000 (52.48%) |
Operating Expenses | $85,448,000 (6.63%) | $80,132,000 (4.01%) | $77,040,000 (32.16%) | $58,293,000 (66.83%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | -$16,100,000 (-805100.00%) | $2,000 (122.22%) | -$9,000 (-139.13%) | $23,000 (283.33%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$58,709,000 (14.87%) | -$68,960,000 (5.94%) | -$73,317,000 (-26.75%) | -$57,846,000 (-67.96%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$58,709,000 (14.87%) | -$68,960,000 (5.94%) | -$73,317,000 (-26.75%) | -$57,846,000 (-67.96%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$58,709,000 (14.87%) | -$68,960,000 (5.94%) | -$73,317,000 (-26.75%) | -$57,846,000 (-67.96%) |
Weighted Average Shares | $51,578,807 (7.42%) | $48,014,645 (5.31%) | $45,594,824 (1.01%) | $45,137,656 (214.23%) |
Weighted Average Shares Diluted | $51,578,807 (7.42%) | $48,014,645 (5.31%) | $45,594,824 (1.01%) | $45,137,656 (214.23%) |
Earning Before Interest & Taxes (EBIT) | -$74,809,000 (-8.48%) | -$68,958,000 (5.96%) | -$73,326,000 (-26.81%) | -$57,823,000 (-67.92%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$85,448,000 (-6.63%) | -$80,132,000 (-4.01%) | -$77,040,000 (-32.16%) | -$58,293,000 (-66.83%) |
PMVP Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $53,352,000 (205.55%) | -$50,545,000 (-3594.81%) | -$1,368,000 (99.05%) | -$143,584,000 (-614.44%) |
Net Cash Flow from Financing | $313,000 (-99.12%) | $35,577,000 (3613.67%) | $958,000 (-52.62%) | $2,022,000 (-99.31%) |
Net Cash Flow from Operations | -$51,282,000 (7.86%) | -$55,657,000 (12.71%) | -$63,760,000 (-36.91%) | -$46,571,000 (-42.25%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $2,348,000 (103.33%) | -$70,591,000 (-10.01%) | -$64,170,000 (65.89%) | -$188,133,000 (-165.29%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $53,756,000 (208.42%) | -$49,583,000 (-849.44%) | $6,616,000 (104.65%) | -$142,235,000 (-606.91%) |
Capital Expenditure | -$404,000 (58.00%) | -$962,000 (87.95%) | -$7,984,000 (-491.85%) | -$1,349,000 (-811.49%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $313,000 (-99.12%) | $35,577,000 (3613.67%) | $958,000 (-52.62%) | $2,022,000 (-99.09%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$35,000 (-202.94%) | $34,000 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $8,872,000 (-28.31%) | $12,375,000 (21.38%) | $10,195,000 (90.92%) | $5,340,000 (176.25%) |
Depreciation Amortization & Accretion | $896,000 (1.01%) | $887,000 (36.46%) | $650,000 (-49.26%) | $1,281,000 (302.83%) |
PMVP Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -29.30% (3.30%) | -30.30% (-10.99%) | -27.30% (-56.00%) | -17.50% (26.78%) |
Return on Average Assets (ROAA) | -26.40% (3.30%) | -27.30% (-9.20%) | -25.00% (-49.70%) | -16.70% (-13.61%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -43.40% (-11.86%) | -38.80% (-0.78%) | -38.50% (-6.06%) | -36.30% (87.91%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.32 (38.46%) | -2.15 (60.16%) | -5.4 (70.06%) | -18.05 (29.58%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 0.44 (-36.84%) | 0.7 (-56.47%) | 1.61 (-52.46%) | 3.4 (-55.70%) |
Debt to Equity Ratio (D/E) | 0.09 (-26.50%) | 0.12 (18.18%) | 0.1 (32.00%) | 0.07 (316.67%) |
Earnings Per Share (EPS) | -1.14 (20.83%) | -1.44 (10.56%) | -1.61 (-25.78%) | -1.28 (46.67%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -1 (15.01%) | -1.18 (25.10%) | -1.57 (-48.21%) | -1.06 (53.60%) |
Book Value Per Share (BVPS) | 3.41 (-27.36%) | 4.7 (-12.90%) | 5.4 (-21.06%) | 6.84 (-72.66%) |
Tangible Assets Book Value Per Share (TABVPS) | 3.71 (-29.38%) | 5.25 (-11.40%) | 5.93 (-19.30%) | 7.35 (-71.13%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (50.00%) | -2 (50.00%) | -4 (73.33%) | -15 (78.26%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.56 (67.51%) | -1.74 (59.12%) | -4.25 (72.73%) | -15.6 (77.65%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 12.22 (-17.32%) | 14.78 (-35.17%) | 22.8 (-7.52%) | 24.66 (-56.67%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$51,686,000 (8.71%) | -$56,619,000 (21.08%) | -$71,744,000 (-49.72%) | -$47,920,000 (-45.71%) |
Enterprise Value (EV) | $41,773,166 (-64.72%) | $118,408,672 (-61.70%) | $309,146,224 (-64.95%) | $882,035,177 (-62.95%) |
Earnings Before Tax (EBT) | -$74,809,000 (-8.48%) | -$68,958,000 (5.96%) | -$73,326,000 (-26.81%) | -$57,823,000 (-67.92%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$73,913,000 (-8.58%) | -$68,071,000 (6.34%) | -$72,676,000 (-28.53%) | -$56,542,000 (-65.73%) |
Invested Capital | $137,232,000 (-35.54%) | $212,881,000 (29.54%) | $164,333,000 (4.50%) | $157,253,000 (6934.12%) |
Working Capital | $161,288,000 (-16.60%) | $193,380,000 (-18.12%) | $236,174,000 (-18.30%) | $289,067,000 (-19.33%) |
Tangible Asset Value | $191,288,000 (-24.14%) | $252,152,000 (-6.72%) | $270,308,000 (-18.48%) | $331,568,000 (-9.29%) |
Market Capitalization | $78,138,166 (-50.73%) | $158,588,672 (-60.08%) | $397,289,224 (-62.10%) | $1,048,286,177 (-61.94%) |
Average Equity | $200,244,750 (-12.10%) | $227,820,750 (-15.31%) | $269,008,500 (-18.46%) | $329,912,250 (128.59%) |
Average Assets | $222,299,500 (-11.90%) | $252,338,750 (-13.79%) | $292,716,000 (-15.53%) | $346,512,250 (47.90%) |
Invested Capital Average | $172,489,750 (-2.93%) | $177,703,000 (-6.70%) | $190,462,000 (19.64%) | $159,199,000 (1288.50%) |
Shares | 51,747,130 (1.15%) | 51,157,636 (12.03%) | 45,665,428 (0.63%) | 45,380,354 (1.35%) |
